Skip to main content

ADVERTISEMENT

CLIPAD

Pave-and-Crack Technique Update at Seven Years
Meeting Exclusives
01/30/2020
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
A novel endovascular strategy to...
01/30/2020
Vascular Disease Management
A Word of Warning on Lysis Therapy
Meeting Exclusives
01/30/2020
“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.
“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.
“Catheter-directed...
01/30/2020
Vascular Disease Management
‘Incredible Efficacy’ of DES Treatment of Long BTK Lesions
Presentation
01/30/2020
Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.
Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.
Robert Lookstein, MD (Icahn...
01/30/2020
Vascular Disease Management
DETOUR Into Long Lesions: A Viable Alternative to Open Fem-Pop Surgery
Meeting Exclusives
01/30/2020
Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.
Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.
Peter Schneider, MD, discussed...
01/30/2020
Vascular Disease Management
Two-Year Data on Percutaneous Deep Vein Arterialization: Findings From the ALPS Registry
Meeting Exclusives
01/29/2020
(Leipzig, Germany) January 29, 2020 -- Two-year registry data on the LimFlow (LimFlow SA, France) percutaneous deep vein arterialization (pDVA) system were presented by Andrej Schmidt, MD (University Hospital Leipzig, Germany) in a first-time...
(Leipzig, Germany) January 29, 2020 -- Two-year registry data on the LimFlow (LimFlow SA, France) percutaneous deep vein arterialization (pDVA) system were presented by Andrej Schmidt, MD (University Hospital Leipzig, Germany) in a first-time...
(Leipzig, Germany) January 29,...
01/29/2020
Vascular Disease Management
The First 24-Month Data Release on the BTK Global Real-World Registry of the Lutonix DCB
Meeting Exclusives
01/29/2020
Two-year results of the Lutonix registry were presented on Wednesday by Dierk Scheinert, MD, who is the study’s co-principal investigator alongside Michael Lichtenberg, MD.
Two-year results of the Lutonix registry were presented on Wednesday by Dierk Scheinert, MD, who is the study’s co-principal investigator alongside Michael Lichtenberg, MD.
Two-year results of the Lutonix...
01/29/2020
Vascular Disease Management